STOK
Stoke Therapeutics Inc
Price:  
12.06 
USD
Volume:  
410,188.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

STOK Probability of Bankruptcy

The Probability of Bankruptcy of Stoke Therapeutics Inc (STOK) is 50.08% . This number represents the probability that STOK will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating STOK's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

STOK - ESG ratings

ESG ratings are directly linked to the cost of capital and STOK's ability to raise funding, both of which can significantly affect the probability of Stoke Therapeutics Inc going bankrupt.

ESG Score 59.35
Environment Score 60.57
Social Score 86.13
Governance Score 31.35
Returns
Historical Returns (5 day) -12.35%
Historical Returns (MTD) -0.41%
Historical Returns (YTD) 129.28%
Historical Returns (13 week) -16.66%
Historical Returns (26 week) -23.86%
Historical Returns (52 week) 134.63%
Efficiency
Asset Turnover 0.06
Receiveable Turnover 37.67
Gross Margin
Operating Margin -700.61%
Pretax Margin -629.86%
Net Margin -629.86%
Return on Asset (ROA) -40.77
Return on Equity (ROE) -54.45
Return on Investments (ROI) -54.45
Price Metrics
Market Cap (M) 638.82
Enterprise Value (M)
52 Week High 17.58
52 Week Low 4.09
Beta 0.90
Average Volume (10 day) 0.75
Average Volume (3 month) 0.55
Price / Earnings (P/E)
Price / Sales (P/S) 37.84
Earnings
EPS -2.10
Revenue CAGR (5 year)
Risk
Current Ratio 5.09
Quick Ratio 4.89